Nuvation Bio (NYSE: NUVB) is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.

Pharmaceutical

Nuvation Bio

David Hung

Evelyn Shu

Susan Baum

Robert Devita

Stephen Dang

Liang Fang

Kerry Wentworth

David Liu

Stacy Markel

David Hanley

Gary Hattersley

The current leadership team at Nuvation Bio has a wealth of experience in the healthcare industry, with members having worked in investment banking, regulatory affairs, and pharmaceuticals. They hold degrees from top institutions in a variety of fields, including medicine, business, and science. This team is well-equipped to navigate the complex world of healthcare and bring innovative new treatments to patients.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Nuvation Bio

Board of Directors

CEO and Executive Team